Fresh2 (FRES) - Cumulative Company Assets

Official company branding of fresh2.co (FRES)

Fresh2 Group Limited (FRES) is building a B2B ecosystem to optimize food supplies for retail and catering, while the price action shown below captures total assets at 0.00. Low brokerage margins and international logistics complexities are capping returns. The company is currently focusing on organic growth and local partnerships, combining the development of its digital service with biotechnological research.

Fresh2 Group Limited (FRES) Company Total Assets: for the period 02/21/2024 - 01/04/2025

Analytical breakdowns for Fresh2 Group Limited

- price and consensus price forecast:
Market Chart Fresh2 Group|FRES - Price Target Chart
- market capitalization data:
Market Valuation Fresh2 Group Limited|FRES - Enterprise Value
- book capitalization data:
Net Asset Value per Share Fresh2 Group|FRES - Book Capitalization|Capitalization to Book Value Ratio fresh2.co|FRES - Company Total Assets
- debt and liquidity data:
Total Debt to Capital Fresh2 Group Limited|FRES - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio Fresh2 Group|FRES - Company Aggregate Debts|Debts to Book Capitalization Fresh2 Group Limited
Fundamental valuation:Fresh2, FRES
Finished products of Fresh2

Fundamental asset selection requires resource analysis via a reverse calculation of total capital based on daily ROA to evaluate the Sortino risk-return ratio. This metric determines the total asset value of Fresh2 Group Limited (FRES), reflecting the scaling efficiency of the digital B2B platform and logistics automation, which allows the trend in consolidated asset volume to be interpreted as an indicator of business model resilience.

Main competitors

A (agilent.com) - Company Total Asset Base|Aggregate Company Assets DGX|Cumulative Company Assets Illumina Inc|Cologuard - Company Total Assets|Company Assets Revvity Corp (RVTY)|BIO - Company Total Assets|Total Business Assets anbio.com NNNN|Sotera Health - Company Total Assets|QDEL: Company Total Assets|Aggregate Company Assets OPKO Corp|CareDx, Inc. (CDNA) - Total Business Assets|MRVI (Maravai LifeSciences) - Company Total Assets|Company Total Assets FLGT|Aggregate Company Assets Standard BioTools (LAB)|Aggregate Company Assets Cytek Biosciences Inc CTKB|OSUR: Cumulative Company Assets|Exagen Inc - Company Assets|Aggregate Company Assets MDXH (MDxHealth SA)|LUCD - Company Total Asset Base|prenetics.com - Company Total Assets|IMDX (Insight Molecular Diagnostics Inc) - Company Total Asset Base|TRIB: Aggregate Company Assets|Company Total Asset Base ProPhase Labs Corp|AIMD - Company Total Assets|Total Asset Value of Company CODX (codiagnostics.com)|Aggregate Company Assets HeartSciences|Aggregate Asset Value Biomerica Inc. BMRA|CDIO (Cardio Diagnostics Holdings, Inc.) - Company Total Assets|VRAX: Company Assets|Bluejay Diagnostics - Aggregate Company Assets|aspirawh.com (AWH) - Company Total Asset Base|AXDX - Company Total Assets|Aggregate Asset Value CNTG|Aggregate Company Assets ENZ (Enzo Biochem, Inc.)|GENE (gtglabs.com) - Cumulative Company Assets|Aggregate Asset Value ME (23andMe Holding Co.)|Company Total Assets psychemedics.com